Ranbaxy Buyers Seek OK On $485M Deal In Generics MDL
Ranbaxy Pharmaceuticals drug purchasers asked a Massachusetts federal court Friday to approve their proposed $485 million global settlement with the generic-drug maker and its parent company over antitrust claims, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article